Search clinical trials for: Infant Formula - Partially hydrolyzed protein
Total 376 results
-
Mercy Health SystemRockford Memorial Hospital Development FoundationTerminatedFeeding ToleranceUnited States
-
Mayo ClinicCompleted
-
Chong Kun Dang PharmaceuticalCompletedLymphoma | Multiple MyelomaKorea, Republic of
-
University of LimerickUnknown
-
Associazione Italiana Ematologia Oncologia PediatricaRecruitingAcute Promyelocytic LeukemiaBelgium, Netherlands, Czechia, Denmark, France, Germany, Ireland, Israel, Italy, Portugal, Spain, Sweden
-
Abbott NutritionCompleted
-
University of HohenheimUniversity Hospital TuebingenCompletedBariatric Surgery CandidateGermany
-
National Taiwan University HospitalTTY BiopharmUnknownPancreatic Ductal Adenocarcinoma
-
Ambryx BiotechnologyTexas A&M University; Baylor UniversityCompleted
-
National University Hospital, SingaporeMerck Sharp & Dohme LLCUnknownUrinary Tract InfectionsSingapore
-
University of CincinnatiWithdrawn
-
University Hospital, GenevaCompletedGastrointestinal Symptoms in Young InfantsSwitzerland
-
Beijing YouAn HospitalUnknownHepatocellular CarcinomaChina
-
Liaoning University of Traditional Chinese MedicineBeijing University of Chinese MedicineUnknown
-
Aarhus University HospitalUniversity of AarhusCompleted
-
Deciphera Pharmaceuticals LLCCompletedLocally Advanced or Metastatic Solid TumorUnited States
-
Beijing YouAn HospitalUnknownHepatocellular CarcinomaChina
-
Aarhus University HospitalUniversity of Copenhagen; University of AarhusCompleted
-
St. Jude Children's Research HospitalRecruiting
-
Mohamed SaadAbbott Nutrition; University of LouisvilleCompletedClostridium Difficile Colitis | Gastrointestinal HemorrhageUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma | Ductal Breast Carcinoma In Situ and other conditionsUnited States
-
University of California, San FranciscoGenentech, Inc.Completed
-
Nationwide Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Prof Curdin ConradCentre Hospitalier Universitaire VaudoisNot yet recruiting
-
Uniformed Services University of the Health SciencesWalter Reed National Military Medical CenterTerminatedTraumatic Brain InjuryUnited States
-
Medical University of ViennaCompleted
-
Janssen Research & Development, LLCCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In Situ | Grade 1 Invasive Breast Carcinoma | Grade 2 Invasive Breast Carcinoma | Grade 3 Invasive Breast Carcinoma | Invasive Ductal and Lobular Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast CarcinomaUnited States
-
Wolfson Medical CenterRecruitingUlcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic MildSwitzerland, Israel, Italy, Netherlands
-
European Organisation for Research and Treatment...University of GlasgowCompleted
-
Aarhus University HospitalUniversity of Copenhagen; University of AarhusCompleted
-
Shandong UniversityUnknown
-
BioromaUnknownGnRH Antagonist | IVF | Poor Responders | Clomiphene Citrate | GnRH AgonistItaly
-
Xi'an International Medical Center HospitalCompleted
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaAustria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
-
Nutricia ResearchINQUIS Clinical Research Ltd.Completed
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
PfizerAstraZenecaCompletedMetastatic Breast CancerKorea, Republic of, United States, Canada, United Kingdom, Australia, Taiwan, Netherlands, Italy, Japan, Belgium, Ireland, Ukraine, Portugal, Germany, Romania, Russian Federation, Turkey
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
Assistance Publique - Hôpitaux de ParisWithdrawnCoronary Thrombosis | Positive Helicobacter Pylori Serology | Supra-aortic Artery ThrombosisFrance
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Brazil, Poland, Sweden, Italy
-
Public Health Service of AmsterdamAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)CompletedGonorrheaNetherlands
-
Yousef ZakhariaEisai Inc.Active, not recruiting
-
AstraZenecaCompletedAdvanced and Metastatic Breast CancerUnited States, United Kingdom
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Korea, Republic of, United Kingdom, Australia, Belgium, China, Denmark, France, Hungary, Portugal, Spain, Taiwan, Thailand, Canada, Italy, Argentina, Brazil, Poland, Singapore, Germany, Greece, Hong Kong, Ukraine, Russian... and more
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
Tehran University of Medical SciencesCompletedFatty Liver | Insulin Resistance | Liver DysfunctionIran, Islamic Republic of
-
Fudan UniversityRecruitingAdvanced Breast Cancer | HR+/HER2- Breast CancerChina